View ValuationBICO Group 향후 성장Future 기준 점검 0/6BICO Group (는) 각각 연간 95.8% 및 7.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 95.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -6.1% 로 예상됩니다.핵심 정보95.8%이익 성장률95.77%EPS 성장률Life Sciences 이익 성장18.6%매출 성장률7.8%향후 자기자본이익률-6.06%애널리스트 커버리지Low마지막 업데이트20 Aug 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Aug 01BICO Group AB (publ) Elects Erik Gatenholm as Board Chair, Effective July 31, 2026BICO Group AB (publ) announced its Board of Directors elected Erik Gatenholm to serve as Board Chair among its members, effective July 31, 2026, until a new Board Chair has been elected by the extraordinary shareholders’ meeting. Erik Gatenholm succeeded Maria Rankka, who announced in a press release from the company on July 6, 2026, that she would be stepping down from her board position and her role as Board Chair effective July 31, 2026.공고 • Jul 06BICO Group AB Announces Board ChangesBICO Group AB announced that Board Chair Maria Rankka notified the Board of Directors that she would step down as Board Chair and board member of BICO Group AB (publ) effective July 31, 2026. Board members Susanne Lithander and Johan Westman also informed the Board that they would leave their Board assignments at the same time. The Board of Directors would therefore resolve to convene an Extraordinary General Meeting to elect new board members.공고 • Apr 01BICO Group AB (publ) Announces Susan Tousi, Alexandra Gatzemeyer and Bengt Sjöholm Decline Re-Election as Members of the Board of DirectorsBICO Group AB (publ) announced that at the AGM to be held on May 7, 2026, Susan Tousi, Alexandra Gatzemeyer and Bengt Sjöholm have declined re-election as members of the Board of Directors.공고 • Mar 24BICO Group AB (publ) to Report Fiscal Year 2026 Results on Feb 17, 2027BICO Group AB (publ) announced that they will report fiscal year 2026 results on Feb 17, 2027공고 • Oct 11BICO Group AB (publ), Annual General Meeting, May 07, 2026BICO Group AB (publ), Annual General Meeting, May 07, 2026.공고 • Jul 03Sartorius Lab Holding GmbH completed the acquisition of MatTek Corporation from BICO Group AB (publ) (OM:BICO).Sartorius Lab Holding GmbH entered into an agreement to acquire MatTek Corporation from BICO Group AB (publ) (OM:BICO) for $80 million on April 4, 2025. The consideration is in cash and debt-free basis. The transaction includes the acquisition of Visikol Inc. During 2024, the business operations of Visikol were merged and operationally integrated into MatTek. For the period ending December 31, 2024, MatTek Corporation reported total revenue of $20 million. MatTek employs more than 80 people. The closing of the transaction is subject to customary regulatory approvals which are expected to be obtained during Q2 2025. Carnegie Investment Bank AB acted as financial advisor for BICO Group AB. Foley & Lardner LLP acted as legal advisor for BICO Group AB. PricewaterhouseCoopers Sweden acted as accountant for BICO Group AB. Led by Michael Bernhardt, Dean W. Sattler, Max Goodman, Alexander Rinne, and John Garces, Milbank LLP acted as legal advisor to Sartorius. Led by Matthias Zahn, Tobias Neukirchner, Kai Schmidt, Steven Wender, Sabrina Trümbach, Christoph Götz, Frank Breitenfeldt, Steve Ratmeyer, Kimberly Setz, and Susann Sturm, Rödl & Partner acted as financial advisor and accountant to Sartorius. Sartorius Lab Holding GmbH completed the acquisition of MatTek Corporation from BICO Group AB (publ) (OM:BICO) on July 1, 2025.공고 • Jun 25BICO Group AB Announces Change in General CounselBICO Group AB announced the appointment of Lars Risberg as General Counsel. He will succeed Andréas Joersjö, who has decided to leave BICO to pursue his career outside the Group. Lars Risberg has 20+ years of working as a General Counsel (GC) and attorney at law whereof the last four years as General Counsel for Vitrolife Group. Prior to that Lars worked as Regional Lead Counsel Northwest Europe for Dekra and as attorney at law at Awa Patent and Setterwalls Business Law firm. Lars Risberg will be joining BICO on June 26 and Andreas Joersjö will remain at BICO until August 31 for handover to Lars Risberg. As General Counsel Lars Risberg will report to BICO’s President and CEO and be a member of the Executive Management.공고 • May 09BICO Group AB (publ) Announces Board ChangesBICO Group AB (publ) at the AGM held on May 8, 2025, the shareholders approved Johan Westman were elected new members of the Board of Directors. The members of the Board of Directors, Ulrika Dellby and Helena Skåntorp, had announced that they were not available for re-election.공고 • Apr 07BICO Group AB (publ) Announces Ulrika Dellby and Helena Skåntorp Decline Re-Election of the Board of DirectorsBICO Group AB (publ) at the Annual General Meeting to be held on May 8, 2025, Ulrika Dellby and Helena Skåntorp have declined re-election of the Board of Directors.공고 • Nov 29Lab14 GmbH acquired Nanoscribe GmbH from BICO Group AB (publ) (OM:BICO) for €26 million.Lab14 GmbH agreed to acquire Nanoscribe GmbH from BICO Group AB (publ) (OM:BICO) for €26 million on November 21, 2024. Following net debt and working capital adjustments, the equity value amounts to €26 million (SEK 294 million). Net proceeds, following transaction expenses, will be used to reduce long term debt. Nanoscribe revenue LTM September 2024 amounted to SEK 230 million (€19.826 million) and the adjusted EBITDA margin to 12 percent according to IFRS. The transaction is expected to close during the fourth quarter 2024. Bryan, Garnier & Co acted as financial advisor and Clemens Höhn, Matthias Rothkopf, Jan D. Bonhage, Christian Dankerl, Markus Ernst and Sonnhild Draack of Hengeler Mueller acted as legal advisor to BICO Group. Lab14 GmbH completed the acquisition of Nanoscribe GmbH from BICO Group AB (publ) (OM:BICO) on November 28, 2024.공고 • Oct 18+ 3 more updatesBICO Group AB (publ) to Report Fiscal Year 2024 Final Results on Mar 20, 2025BICO Group AB (publ) announced that they will report fiscal year 2024 final results on Mar 20, 2025공고 • Oct 09BICO Group AB (publ), Annual General Meeting, May 08, 2025BICO Group AB (publ), Annual General Meeting, May 08, 2025.공고 • Jul 10BICO Group AB Announces Management ChangesBICO Group AB announced the appointment of Andréas Joersjö as General Counsel. He will succeed Lotta Bus who has decided to leave BICO to pursue her career outside the Group. Andréas Joersjö will assume his new position by mid-October 2024 at the latest. Andréas Joersjö has 15+ years of experience working in an international business environment as General Counsel, lawyer, and advisor. Before joining BICO, Andréas has worked for Swedish law firms Delphi and Hammarskiöld & Co, in connection with which he has had several in-house assignments with large companies in various businesses, as well as PwC, and most recently as General Counsel for Hedin Group. For Hedin Group he established and headed the Group's Legal & Compliance team and was also a member of the Executive Management. Andréas Joersjö will report to BICO's President and CEO and be a member of the Executive Management. He will assume his position by mid-October 2024 at the latest.공고 • May 23BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of DirectorsBICO Group AB (publ) at its AGM held on May 20, 2024, approved the election of Alexandra Gatzemeyer as new member of the Board of Directors.공고 • Apr 19BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024BICO Group AB (publ) announced the appointment of Anders Fogelberg as Chief Commercial Officer (CCO). Commercial excellence has been defined as one of the top strategic priorities for BICO and this position is pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the portfolio and further explore opportunities for collaborations and partnerships. Anders Fogelberg has 20+ years' experience of working with marketing and sales & business development in global organizations. He has extensive experience from different leadership positions foremost as a Managing Director for the SKF Group in Malaysia and Indonesia respectively. Before joining BICO, Anders has worked in the Med Tech industry now latest as Chief Marketing Officer and Head of Sales for Profundus and before that as CEO for Bellman & Symfon. Anders Fogelberg will assume his new position on June 13, 2024. The CCO role is newly established, will be a member of the Executive Management and report to BICO's CEO and President. The CCO will be main responsible for the commercial activities within the BICO Group and ensure cooperation between subsidiaries and that long-term partnerships are built with relevant partners throughout the global life science industry.공고 • Apr 16BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of DirectorsBICO Group AB (publ) at the Annual General Meeting on May 20, 2024, Gerry Mackay and Erik Gatenholm have declined re-election of the Board of Directors.공고 • Mar 15BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025BICO Group AB (publ) announced that they will report fiscal year 2024 results on Feb 19, 2025공고 • Mar 06+ 1 more updateBICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024BICO Group AB (publ) announced that they will report Q3, 2024 results on Nov 13, 2024공고 • Jan 25BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HRBICO Group AB (publ) announced the appointment of Catharina Nordlund as Global Head of HR. The role will further strengthen the Executive Management and be responsible for shaping and executing BICO's global HR strategy in order to build a people and high-performance culture. Catharina Nordlund has 25+ years' experience of Human Resources (HR), Learning & Development as well as Sales and Marketing in global organizations. She has held various positions within the medtech and the life science industries at companies such as Cochlear Bone Anchored Solutions, Mölnlycke Health Care and Pfizer, and now latest as VP Global HR for Surgical Science. Her vast experience covers functional responsibility for HR as well as line manager positions within sales from the life science industry. Catharina Nordlund will be part of the Executive Management and report to the CEO and President.공고 • Nov 15+ 4 more updatesBICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024BICO Group AB (publ) announced that they will report fiscal year 2023 results on Mar 15, 2024공고 • Aug 22+ 1 more updateBICO Group AB (publ) Announces Chief Executive Officer ChangesBICO Group AB (publ) announced that Erik Gatenholm, after initiating discussions with the Board of Directors, has decided to step down as CEO of BICO Group. Maria Forss has been appointed as CEO. Maria Forss will assume office on November 27, 2023, or sooner. Maria Forss (born 1972) has extensive international experience from leading positions in both medtech and pharma companies, such as Vitrolife and AstraZeneca. The last years within Vitrolife Maria Forss has as the Senior Vice President led the Consumables Business Area and before that she was the Vice President of Business Development and Global Marketing. Maria Forss has successfully developed businesses through the whole value chain and in the whole product life cycle as well as acquisitions and integration of companies. In order to enable a seamless transition, Erik Gatenholm will remain in his current position until Maria Forss assumes as new President and CEO. To secure continuity Erik Gatenholm will, as major shareholder, also remain in his role as board member of BICO.공고 • May 10BICO Group AB (publ) Elects Gerry Mackay to Its Board of DirectorsBICO Group AB (publ) at its Annual General Meeting held on 9 May 2023, elected Gerry Mackay to Its Board of Directors.공고 • May 05BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024BICO Group AB (publ) announced that they will report fiscal year 2023 results on Feb 20, 2024공고 • Jan 06BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023BICO Group AB announced the appointment of Marius Balger as Chief Operating Officer, as BICO continues to accelerate its growth journey across geographies and business strategies. Mr.Balger will be part of the Executive Management team and report directly to President & CEO Erik Gatenholm. As COO, Mr. Balger will take office 1 March 2023 and lead the strategic development of BICO’s operational efficiency and cost control. Mr. Balger brings nearly 20 years of experience in the global life science industry, most recently serving as Senior Vice President, Commercial Operations at Tecan AG, a public life science company headquartered in Zurich, where he has worked since 2017. Before Tecan AG, Mr. Balger had a long and esteemed career as CEO, successfully growing a global Contract Development and Manufacturing Organization for life science and in-vitro diagnostics laboratory instrumentation. In line with BICO's previously communicated strategy with a focus on cost control, operational efficiency, and decentralized organizational structure the Executive Management of BICO Group will, as of January 5, 2023, consist of the following people: President and CEO Erik Gatenholm; CTO Hector Martinez; CFO Jacob Thordenberg and SVP & General Counsel & HR Lotta Bus. As of 1 March 2023, both COO Marius Balger and Head of Corporate Development & M&A Artur Aira are included in the Executive Management team.공고 • Jan 03BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFOBICO Group AB announced the appointment of Jacob Thordenberg as Group CFO. Thordenberg will begin his employment in his new position as Group CFO, on January 2, 2023, and will be part of the company's executive management team. Jacob Thordenberg has a Master of Science in Corporate and Financial Management, and has more than ten years' experience from mergers and acquisitions from Deloitte, Telia and BICO Group AB. Most recently he comes from a role as Head of M&A at BICO, where he has been since December 2021. Thordenberg succeeds Mikael Engblom, who has been interim Group CFO since May 2022. Engblom will continue to advise the company on strategic projects.공고 • Nov 10BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023BICO Group AB (publ) announced that they will report Q2, 2023 results on Jul 20, 2023공고 • May 18BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023BICO Group AB (publ) announced that they will report fiscal year 2023 results on Feb 22, 2023이익 및 매출 성장 예측OTCPK:BCCO.Y - 애널리스트 향후 추정치 및 과거 재무 데이터 (SEK Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20281,859-46166210212/31/20271,686-12670112212/31/20261,622-227316526/30/20261,504-1,331-1511N/A3/31/20261,492-1,4771539N/A12/31/20251,497-1,5804368N/A9/30/20251,561-1,270159199N/A6/30/20251,543-424216275N/A3/31/20251,642-323176252N/A12/31/20241,727-10773158N/A9/30/20241,609-80348139N/A6/30/20241,828-583-3598N/A3/31/20241,941-729-98101N/A12/31/20232,010-788-113178N/A9/30/20232,210-497-435-53N/A6/30/20232,202-390-527-72N/A3/31/20232,174-117-643-140N/A12/31/20222,162-85-799-269N/A9/30/20222,08941-817-313N/A6/30/20221,833-130-872-457N/A3/31/20221,624-224-816-462N/A12/31/20211,284-228-676-409N/A9/30/2021914-188-529-321N/A6/30/2021676-96-328-150N/A3/31/2021414-50-156-34N/A12/31/2020323-36-160-59N/A8/31/2020196-62-154-72N/A5/31/2020175-49N/A-70N/A2/29/2020165-24N/A-53N/A11/30/2019152-5N/A-31N/A8/31/20191191N/A-16N/A5/31/20191013N/A-16N/A2/28/2019814N/A-1N/A11/30/2018632N/A-12N/A8/31/2018501N/A-12N/A5/31/2018391N/A-6N/A2/28/201828-2N/A-8N/A11/30/201722-2N/A-8N/A8/31/201716-1N/A-1N/A8/31/20166-1N/A-2N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: BCCO.Y 향후 3년 동안 수익성이 없을 것으로 예상됩니다.수익 vs 시장: BCCO.Y 향후 3년 동안 수익성이 없을 것으로 예상됩니다.고성장 수익: BCCO.Y 향후 3년 동안 수익성이 없을 것으로 예상됩니다.수익 대 시장: BCCO.Y 의 수익(연간 7.8%)이 US 시장(연간 12.9%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: BCCO.Y 의 수익(연간 7.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: BCCO.Y는 3년 뒤에도 수익성이 없을 것으로 전망됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YPharmaceuticals-biotech 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/21 17:25종가2026/07/15 00:00수익2026/06/30연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스BICO Group AB (publ)는 4명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Maria Karlsson OsipovaDNB CarnegieKristofer Liljeberg-SvenssonDNB CarnegieLudvig LundgrenNordea Markets1명의 분석가 더 보기
공고 • Aug 01BICO Group AB (publ) Elects Erik Gatenholm as Board Chair, Effective July 31, 2026BICO Group AB (publ) announced its Board of Directors elected Erik Gatenholm to serve as Board Chair among its members, effective July 31, 2026, until a new Board Chair has been elected by the extraordinary shareholders’ meeting. Erik Gatenholm succeeded Maria Rankka, who announced in a press release from the company on July 6, 2026, that she would be stepping down from her board position and her role as Board Chair effective July 31, 2026.
공고 • Jul 06BICO Group AB Announces Board ChangesBICO Group AB announced that Board Chair Maria Rankka notified the Board of Directors that she would step down as Board Chair and board member of BICO Group AB (publ) effective July 31, 2026. Board members Susanne Lithander and Johan Westman also informed the Board that they would leave their Board assignments at the same time. The Board of Directors would therefore resolve to convene an Extraordinary General Meeting to elect new board members.
공고 • Apr 01BICO Group AB (publ) Announces Susan Tousi, Alexandra Gatzemeyer and Bengt Sjöholm Decline Re-Election as Members of the Board of DirectorsBICO Group AB (publ) announced that at the AGM to be held on May 7, 2026, Susan Tousi, Alexandra Gatzemeyer and Bengt Sjöholm have declined re-election as members of the Board of Directors.
공고 • Mar 24BICO Group AB (publ) to Report Fiscal Year 2026 Results on Feb 17, 2027BICO Group AB (publ) announced that they will report fiscal year 2026 results on Feb 17, 2027
공고 • Oct 11BICO Group AB (publ), Annual General Meeting, May 07, 2026BICO Group AB (publ), Annual General Meeting, May 07, 2026.
공고 • Jul 03Sartorius Lab Holding GmbH completed the acquisition of MatTek Corporation from BICO Group AB (publ) (OM:BICO).Sartorius Lab Holding GmbH entered into an agreement to acquire MatTek Corporation from BICO Group AB (publ) (OM:BICO) for $80 million on April 4, 2025. The consideration is in cash and debt-free basis. The transaction includes the acquisition of Visikol Inc. During 2024, the business operations of Visikol were merged and operationally integrated into MatTek. For the period ending December 31, 2024, MatTek Corporation reported total revenue of $20 million. MatTek employs more than 80 people. The closing of the transaction is subject to customary regulatory approvals which are expected to be obtained during Q2 2025. Carnegie Investment Bank AB acted as financial advisor for BICO Group AB. Foley & Lardner LLP acted as legal advisor for BICO Group AB. PricewaterhouseCoopers Sweden acted as accountant for BICO Group AB. Led by Michael Bernhardt, Dean W. Sattler, Max Goodman, Alexander Rinne, and John Garces, Milbank LLP acted as legal advisor to Sartorius. Led by Matthias Zahn, Tobias Neukirchner, Kai Schmidt, Steven Wender, Sabrina Trümbach, Christoph Götz, Frank Breitenfeldt, Steve Ratmeyer, Kimberly Setz, and Susann Sturm, Rödl & Partner acted as financial advisor and accountant to Sartorius. Sartorius Lab Holding GmbH completed the acquisition of MatTek Corporation from BICO Group AB (publ) (OM:BICO) on July 1, 2025.
공고 • Jun 25BICO Group AB Announces Change in General CounselBICO Group AB announced the appointment of Lars Risberg as General Counsel. He will succeed Andréas Joersjö, who has decided to leave BICO to pursue his career outside the Group. Lars Risberg has 20+ years of working as a General Counsel (GC) and attorney at law whereof the last four years as General Counsel for Vitrolife Group. Prior to that Lars worked as Regional Lead Counsel Northwest Europe for Dekra and as attorney at law at Awa Patent and Setterwalls Business Law firm. Lars Risberg will be joining BICO on June 26 and Andreas Joersjö will remain at BICO until August 31 for handover to Lars Risberg. As General Counsel Lars Risberg will report to BICO’s President and CEO and be a member of the Executive Management.
공고 • May 09BICO Group AB (publ) Announces Board ChangesBICO Group AB (publ) at the AGM held on May 8, 2025, the shareholders approved Johan Westman were elected new members of the Board of Directors. The members of the Board of Directors, Ulrika Dellby and Helena Skåntorp, had announced that they were not available for re-election.
공고 • Apr 07BICO Group AB (publ) Announces Ulrika Dellby and Helena Skåntorp Decline Re-Election of the Board of DirectorsBICO Group AB (publ) at the Annual General Meeting to be held on May 8, 2025, Ulrika Dellby and Helena Skåntorp have declined re-election of the Board of Directors.
공고 • Nov 29Lab14 GmbH acquired Nanoscribe GmbH from BICO Group AB (publ) (OM:BICO) for €26 million.Lab14 GmbH agreed to acquire Nanoscribe GmbH from BICO Group AB (publ) (OM:BICO) for €26 million on November 21, 2024. Following net debt and working capital adjustments, the equity value amounts to €26 million (SEK 294 million). Net proceeds, following transaction expenses, will be used to reduce long term debt. Nanoscribe revenue LTM September 2024 amounted to SEK 230 million (€19.826 million) and the adjusted EBITDA margin to 12 percent according to IFRS. The transaction is expected to close during the fourth quarter 2024. Bryan, Garnier & Co acted as financial advisor and Clemens Höhn, Matthias Rothkopf, Jan D. Bonhage, Christian Dankerl, Markus Ernst and Sonnhild Draack of Hengeler Mueller acted as legal advisor to BICO Group. Lab14 GmbH completed the acquisition of Nanoscribe GmbH from BICO Group AB (publ) (OM:BICO) on November 28, 2024.
공고 • Oct 18+ 3 more updatesBICO Group AB (publ) to Report Fiscal Year 2024 Final Results on Mar 20, 2025BICO Group AB (publ) announced that they will report fiscal year 2024 final results on Mar 20, 2025
공고 • Oct 09BICO Group AB (publ), Annual General Meeting, May 08, 2025BICO Group AB (publ), Annual General Meeting, May 08, 2025.
공고 • Jul 10BICO Group AB Announces Management ChangesBICO Group AB announced the appointment of Andréas Joersjö as General Counsel. He will succeed Lotta Bus who has decided to leave BICO to pursue her career outside the Group. Andréas Joersjö will assume his new position by mid-October 2024 at the latest. Andréas Joersjö has 15+ years of experience working in an international business environment as General Counsel, lawyer, and advisor. Before joining BICO, Andréas has worked for Swedish law firms Delphi and Hammarskiöld & Co, in connection with which he has had several in-house assignments with large companies in various businesses, as well as PwC, and most recently as General Counsel for Hedin Group. For Hedin Group he established and headed the Group's Legal & Compliance team and was also a member of the Executive Management. Andréas Joersjö will report to BICO's President and CEO and be a member of the Executive Management. He will assume his position by mid-October 2024 at the latest.
공고 • May 23BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of DirectorsBICO Group AB (publ) at its AGM held on May 20, 2024, approved the election of Alexandra Gatzemeyer as new member of the Board of Directors.
공고 • Apr 19BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024BICO Group AB (publ) announced the appointment of Anders Fogelberg as Chief Commercial Officer (CCO). Commercial excellence has been defined as one of the top strategic priorities for BICO and this position is pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the portfolio and further explore opportunities for collaborations and partnerships. Anders Fogelberg has 20+ years' experience of working with marketing and sales & business development in global organizations. He has extensive experience from different leadership positions foremost as a Managing Director for the SKF Group in Malaysia and Indonesia respectively. Before joining BICO, Anders has worked in the Med Tech industry now latest as Chief Marketing Officer and Head of Sales for Profundus and before that as CEO for Bellman & Symfon. Anders Fogelberg will assume his new position on June 13, 2024. The CCO role is newly established, will be a member of the Executive Management and report to BICO's CEO and President. The CCO will be main responsible for the commercial activities within the BICO Group and ensure cooperation between subsidiaries and that long-term partnerships are built with relevant partners throughout the global life science industry.
공고 • Apr 16BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of DirectorsBICO Group AB (publ) at the Annual General Meeting on May 20, 2024, Gerry Mackay and Erik Gatenholm have declined re-election of the Board of Directors.
공고 • Mar 15BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025BICO Group AB (publ) announced that they will report fiscal year 2024 results on Feb 19, 2025
공고 • Mar 06+ 1 more updateBICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024BICO Group AB (publ) announced that they will report Q3, 2024 results on Nov 13, 2024
공고 • Jan 25BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HRBICO Group AB (publ) announced the appointment of Catharina Nordlund as Global Head of HR. The role will further strengthen the Executive Management and be responsible for shaping and executing BICO's global HR strategy in order to build a people and high-performance culture. Catharina Nordlund has 25+ years' experience of Human Resources (HR), Learning & Development as well as Sales and Marketing in global organizations. She has held various positions within the medtech and the life science industries at companies such as Cochlear Bone Anchored Solutions, Mölnlycke Health Care and Pfizer, and now latest as VP Global HR for Surgical Science. Her vast experience covers functional responsibility for HR as well as line manager positions within sales from the life science industry. Catharina Nordlund will be part of the Executive Management and report to the CEO and President.
공고 • Nov 15+ 4 more updatesBICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024BICO Group AB (publ) announced that they will report fiscal year 2023 results on Mar 15, 2024
공고 • Aug 22+ 1 more updateBICO Group AB (publ) Announces Chief Executive Officer ChangesBICO Group AB (publ) announced that Erik Gatenholm, after initiating discussions with the Board of Directors, has decided to step down as CEO of BICO Group. Maria Forss has been appointed as CEO. Maria Forss will assume office on November 27, 2023, or sooner. Maria Forss (born 1972) has extensive international experience from leading positions in both medtech and pharma companies, such as Vitrolife and AstraZeneca. The last years within Vitrolife Maria Forss has as the Senior Vice President led the Consumables Business Area and before that she was the Vice President of Business Development and Global Marketing. Maria Forss has successfully developed businesses through the whole value chain and in the whole product life cycle as well as acquisitions and integration of companies. In order to enable a seamless transition, Erik Gatenholm will remain in his current position until Maria Forss assumes as new President and CEO. To secure continuity Erik Gatenholm will, as major shareholder, also remain in his role as board member of BICO.
공고 • May 10BICO Group AB (publ) Elects Gerry Mackay to Its Board of DirectorsBICO Group AB (publ) at its Annual General Meeting held on 9 May 2023, elected Gerry Mackay to Its Board of Directors.
공고 • May 05BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024BICO Group AB (publ) announced that they will report fiscal year 2023 results on Feb 20, 2024
공고 • Jan 06BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023BICO Group AB announced the appointment of Marius Balger as Chief Operating Officer, as BICO continues to accelerate its growth journey across geographies and business strategies. Mr.Balger will be part of the Executive Management team and report directly to President & CEO Erik Gatenholm. As COO, Mr. Balger will take office 1 March 2023 and lead the strategic development of BICO’s operational efficiency and cost control. Mr. Balger brings nearly 20 years of experience in the global life science industry, most recently serving as Senior Vice President, Commercial Operations at Tecan AG, a public life science company headquartered in Zurich, where he has worked since 2017. Before Tecan AG, Mr. Balger had a long and esteemed career as CEO, successfully growing a global Contract Development and Manufacturing Organization for life science and in-vitro diagnostics laboratory instrumentation. In line with BICO's previously communicated strategy with a focus on cost control, operational efficiency, and decentralized organizational structure the Executive Management of BICO Group will, as of January 5, 2023, consist of the following people: President and CEO Erik Gatenholm; CTO Hector Martinez; CFO Jacob Thordenberg and SVP & General Counsel & HR Lotta Bus. As of 1 March 2023, both COO Marius Balger and Head of Corporate Development & M&A Artur Aira are included in the Executive Management team.
공고 • Jan 03BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFOBICO Group AB announced the appointment of Jacob Thordenberg as Group CFO. Thordenberg will begin his employment in his new position as Group CFO, on January 2, 2023, and will be part of the company's executive management team. Jacob Thordenberg has a Master of Science in Corporate and Financial Management, and has more than ten years' experience from mergers and acquisitions from Deloitte, Telia and BICO Group AB. Most recently he comes from a role as Head of M&A at BICO, where he has been since December 2021. Thordenberg succeeds Mikael Engblom, who has been interim Group CFO since May 2022. Engblom will continue to advise the company on strategic projects.
공고 • Nov 10BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023BICO Group AB (publ) announced that they will report Q2, 2023 results on Jul 20, 2023
공고 • May 18BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023BICO Group AB (publ) announced that they will report fiscal year 2023 results on Feb 22, 2023